Levothyroxine Sodium
- Product NDC
- 63323-885
- Requested package NDC
- 63323-885-10
- 11-digit product format
- 633230885
- Labeler code
- 63323
- Product ID
- 63323-885_09cdd46f-eae9-4faa-b3b3-67fcd71b62ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA210632
- Marketing category
- NDA
- Marketing start
- 2018-05-29
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 20 ug/mL
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N210632-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | |
| N210632-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | |
| N210632-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N210632-001 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | |
| N210632-001 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | |
| N210632-001 | 12636270 | 2036-12-01 | Drug product | 2026-06-18 | |
| N210632-001 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | |
| N210632-002 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | |
| N210632-002 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | |
| N210632-002 | 12636270 | 2036-12-01 | Drug product | 2026-06-18 | |
| N210632-002 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | |
| N210632-003 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | |
| N210632-003 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | |
| N210632-003 | 12636270 | 2036-12-01 | Drug product | 2026-06-18 | |
| N210632-003 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N210632-002 | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N210632-003 | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N210632-001 | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2019-04-11 | 8072bd15b7f6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N210632-001 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-001 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-001 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-002 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-002 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-002 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-003 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-003 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N210632-003 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-001 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-001 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-001 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-002 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-002 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-002 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-003 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-003 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N210632-003 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-001 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-001 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-001 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-002 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-002 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-002 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-003 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-003 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N210632-003 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-001 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-001 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-001 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-002 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-002 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-002 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-003 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-003 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N210632-003 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-001 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-001 | 11135190 | 2036-12-01 | Drug product | 2021-10-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-001 | 9782376 | 2036-12-01 | Drug product | 2019-06-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N210632-002 | 10398669 | 2036-12-01 | Drug product | 2019-09-13 | b8a1b40f171c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVOTHYROXINE SODIUM | 20 ug/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9J765S329G | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-885-10 | Levothyroxine Sodium | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 4 | |
| 63323-885-10 | Levothyroxine Sodium | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 4 | |
| 63323-885-12 | Levothyroxine Sodium | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 1 | |
| 63323-885-12 | Levothyroxine Sodium | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 63323-885-14 | Levothyroxine Sodium | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 1 | |
| 63323-885-14 | Levothyroxine Sodium | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-885-10 | ML - Milliliter | 63323-885 | d4060697-dbe3-41da-84bb-1a1e213d57a1 | 1 | 2019-06-19 |
| 63323-885-12 | ML - Milliliter | 63323-885 | fd862941-90d5-4e9d-973b-75c6f82ef0a4 | 1 | 2021-03-02 |
| 63323-885-14 | ML - Milliliter | 63323-885 | 1aa98018-ab28-492b-8922-3ae6eaf6a42e | 1 | 2021-03-02 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-885 | LEVOTHYROXINE SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20250419_08f4b1f8-6807-47e7-bef8-8d1972aa0557.zip |
| 63323-885 | LEVOTHYROXINE SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 2 package rows | 20201210_50b1c8a4-75b6-49c8-80fc-3841ee80b183.zip |
| 63323-885 | LEVOTHYROXINE SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 2 package rows | 20201210_388a1f15-8c1c-46a5-997f-7f326f696b59.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | 210632 NDA210632 63323-885-10 63323-885 63323088510 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 388a1f15-8c1c-46a5-997f-7f326f696b59 | 2020-12-04 | Boxed warning, Warnings, Adverse reactions | 210632 NDA210632 63323-885 |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 50b1c8a4-75b6-49c8-80fc-3841ee80b183 | 2020-12-04 | Boxed warning, Warnings, Adverse reactions | 210632 NDA210632 63323-885 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2166193 | levothyroxine sodium 100 MCG in 5 mL Injection | PSN | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166196 | levothyroxine sodium 200 MCG in 5 mL Injection | PSN | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166148 | levothyroxine sodium 500 MCG in 5 mL Injection | PSN | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166193 | 5 ML levothyroxine sodium 0.02 MG/ML Injection | SCD | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166196 | 5 ML levothyroxine sodium 0.04 MG/ML Injection | SCD | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166148 | 5 ML levothyroxine sodium 0.1 MG/ML Injection | SCD | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166193 | levothyroxine sodium 100 MCG per 5 ML Injection | SY | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166148 | levothyroxine sodium 100 MCG/ML in 5 ML Injection | SY | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166193 | levothyroxine sodium 20 MCG/ML in 5 ML Injection | SY | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166196 | levothyroxine sodium 200 MCG per 5 ML Injection | SY | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166196 | levothyroxine sodium 40 MCG/ML in 5 ML Injection | SY | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166148 | levothyroxine sodium 500 MCG per 5 ML Injection | SY | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 4 |
| 2166193 | levothyroxine sodium 100 MCG in 5 mL Injection | PSN | 388a1f15-8c1c-46a5-997f-7f326f696b59 | 1 |
| 2166193 | levothyroxine sodium 100 MCG in 5 mL Injection | PSN | 50b1c8a4-75b6-49c8-80fc-3841ee80b183 | 1 |
| 2166193 | 5 ML levothyroxine sodium 0.02 MG/ML Injection | SCD | 388a1f15-8c1c-46a5-997f-7f326f696b59 | 1 |
| 2166193 | 5 ML levothyroxine sodium 0.02 MG/ML Injection | SCD | 50b1c8a4-75b6-49c8-80fc-3841ee80b183 | 1 |
| 2166193 | levothyroxine sodium 100 MCG per 5 ML Injection | SY | 388a1f15-8c1c-46a5-997f-7f326f696b59 | 1 |
| 2166193 | levothyroxine sodium 100 MCG per 5 ML Injection | SY | 50b1c8a4-75b6-49c8-80fc-3841ee80b183 | 1 |
| 2166193 | levothyroxine sodium 20 MCG/ML in 5 ML Injection | SY | 388a1f15-8c1c-46a5-997f-7f326f696b59 | 1 |
| 2166193 | levothyroxine sodium 20 MCG/ML in 5 ML Injection | SY | 50b1c8a4-75b6-49c8-80fc-3841ee80b183 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63323-885-10 | 63323088510 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-10) / 5 mL in 1 VIAL, SINGLE-DOSE | 2018-05-29 | 0000-00-00 | No | No | Current |